Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDS Head of Department makes a splash in many international news sites with the published results of his 10 year ProtecT Study. A trial of 1,643 men with small prostate cancers resulted in the same 99% survival rate after a decade for those who had had surgery, radiotherapy or simply monitored the tumour.

Prof Freddie Hamdy © Academy of Medical Sciences
Professor Freddie Hamdy

Read more in the publication in the New England Journal of Medicine: http://www.nejm.org/doi/full/10.1056/NEJMoa1606220#t=article

BBC: http://www.bbc.co.uk/news/health-37362572

Guardian: https://www.theguardian.com/society/2016/sep/14/monitoring-prostate-cancer-effective-treatment

Telegraph: http://www.telegraph.co.uk/news/2016/09/14/prostate-cancer-survival-rates-equally-high-if-you-monitor-disea/

Financial Times: https://www.ft.com/content/34f1a9c8-78f7-11e6-a0c6-39e2633162d5

The Times: http://www.thetimes.co.uk/article/most-prostate-cancer-sufferers-can-avoid-pain-of-early-surgery-6rp8q8ml8

The Washington Post: https://www.washingtonpost.com/news/to-your-health/wp/2016/09/14/almost-all-men-with-early-prostate-cancer-survive-10-years-regardless-of-treatment/

New York Times online: http://www.nytimes.com/aponline/2016/09/14/health/ap-eu-med-prostate-cancer.html?_r=1 

NBC News online: http://www.nbcnews.com/health/health-news/all-prostate-cancer-treatments-about-equally-effective-study-finds-n648471

CBC online (Canada): http://www.cbc.ca/news/health/prostate-cancer-1.3762576 

Daily Telegraph Australia online: http://www.dailytelegraph.com.au/news/breaking-news/treat-or-monitor-early-prostate-cancer/news-story/9cff4fc64f9e56a5053a3103949a0ecf 

Channel NewsAsia online: http://www.channelnewsasia.com/news/world/prostate-cancer-options-show-little-difference-in-survival/3128170.html 

Further coverage

Call to watch and wait on male cancer

The Daily Mirror, 07/11/2017, p.15, Rosie Taylor

Too many men are diagnosed with prostate cancer when it will not harm them, Oxford University’s Professor Freddie Hamdy said. He argued that in many cases they should not be told they have it. He said that out of 500 diagnoses, 75% avoided treatment for three years and 44% for more than 10. He said patients “driven by anxiety” to tackle the cancer often opted for needless surgery or radiotherapy, leading to urinary and bowel problems and sexual dysfunction.

Ignore cancer call

The Sun, 07/11/2017, p.24, Unattributed

https://www.thesun.co.uk/news/4856964/men-prostrate-cancer-stress-oxford-professor/

Why not treating prostate cancer ‘is best for most men’

Daily Mail, 07/11/2017, p.27, Sophie Borland & Rosie Taylor

http://www.dailymail.co.uk/news/article-5056043/Prostate-cancer-patients-better-not-diagnosed.html

‘Better off undiagnosed’

Daily Mail (Ireland), 07/11/2017, p.12, Katie O’Neill

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Transplant kidney survival rate improves with new method of transportation

Publication Research

New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.